Announcements Trials
Browse Landscape

Phase

Phase 4 26Phase 3 19Phase NA 17Phase 2 13Phase 1/2 3Phase 1 2Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1

Conditions

Pain 1Neoplasms 1Dyspnea 1Chronic Pain 1Breakthrough Pain 1

Interventions

pembrolizumab 410Cyclophosphamide 394Carboplatin 306Gemcitabine 286Nivolumab 276Paclitaxel 274Cisplatin 252Radiotherapy 225Dexamethasone 210Bevacizumab 209fludarabine 192Docetaxel 187Rituximab 183Capecitabine 171Oxaliplatin 158Lenalidomide 157Fluorouracil 152Temozolomide 138Cytarabine 135Etoposide 128Irinotecan 124Cetuximab 123fludarabine phosphate 120Injections 118venetoclax 116Ipilimumab 115Doxorubicin 114Azacitidine 108130-nm albumin-bound paclitaxel 108Pemetrexed 107

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Fentanyl × Clear all
NCT05037539 2022-08-31

Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain

Department of Medical Services Ministry of Public Health of Thailand

Phase 1/2 Completed
20 enrolled

Breakthrough Pain

NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Other

Dyspnea

NCT01248611 2014-05-12

NFCP1-2010

St. Olavs Hospital

Phase 1/2 Completed
10 enrolled

Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡